Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer
Not Applicable
Completed
- Conditions
- Breast CancerJoint Pain
- Interventions
- Drug: Blue CitrusDrug: Placebo
- Registration Number
- NCT00702858
- Lead Sponsor
- Legacy Health System
- Brief Summary
This purpose of this study is to determine if the herbal compound, Blue Citrus, decreases joint and bone pain associated with Aromotase Inhibitor therapy (AIT).
Another purpose of the study is to find out if Blue Citrus improves how you feel while taking AIT and if your quality of life improves.
- Detailed Description
Post-menopausal women currently on AIT for breast cancer treatment who self-report musculoskeletal side effects related to AIT to their physicians.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
- Post Menopausal - evidenced by no menses for the past 6 months or FSH level >40
- Patient complaints of musculoskeletal symptoms
- Currently taking AIT for ER positive postmenopausal breast cancer
Read More
Exclusion Criteria
- Previously taken Blue Citrus
- Presence of bone metastasis
- Unable to complete VAS Pain Scale
- Unable to comply/complete SF 12 Quality of Life survey
- Plan to discontinue AIT in less then six months
- Unable to complete ADL scale
- Have diagnosis of fibromyalgia
- Have diagnosis of rheumatoid arthritis
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description 1 Blue Citrus Blue Citrus either months 1-3 or 4-6 2 Placebo Placebo
- Primary Outcome Measures
Name Time Method Determine if Blue Citrus decreases musculoskeletal symptoms while on AIT as compared to Placebo 6 months
- Secondary Outcome Measures
Name Time Method Determine if Blue Citrus use leads to reduction in use of other pain medications compared to placebo 6 months Determine if Blue Citrus compared to placebo improves Quality of Life,improves the ability to perform Activities of Daily Living 6 months